SCD and nonpapillary renal cell carcinoma: Stearoyl-CoA desaturase (SCD1) inhibition significantly reduced cancer cell proliferation and increased cisplatin sensitivity, suggesting that this pathway can be involved in ccRCC chemotherapy resistance [53].